Interestingly, GA development has only been observed during the treatment of AMD, in which GA is part of the natural history of the disease, and has not been observed during the course of other diseases managed by multiple injections of anti-VEGF drugs. This evidence concerns the gene VEGFA and age-related macular degeneration.